Sep 14, 2020 / 05:30PM GMT
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director
I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Quickly before we get started, I just need to read a disclosure statement. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley representative.
With that, very pleased to have argenx with me and Tim Van. Tim, I can never say your last name. I'm sorry.
Timothy Van Hauwermeiren - argenx SE - CEO & Executive Director
Just call it Tim.
Matthew Kelsey Harrison - Morgan Stanley, Research Division - Executive Director
Tim, who's CEO; and Keith Woods, who's the COO.
argenx SE at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
